On the Move with Haemophilia

An educational resource for parents, carers and teachers, “On the Move with Haemophilia” was developed in collaboration with Haemophilia Foundation Australia and Haemophilia Foundation of New Zealand to improve confidence in discussing and managing exercise for young people with haemophilia.

See more...

Points - 1.0 CME/CE Credit

An Update on Emerging Therapies for Cystic Fibrosis and Their Implications for Clinical Outcomes

Recorded during the 2018 European Cystic Fibrosis Society Conference in Belgrade, Serbia, this webcast features international experts’ views on new and emerging clinical trials on CFTR modulators and implications for people with CF.

See more...

Points - 1.5 CME/CE Credit

New Horizons in Non-Hodgkin’s Lymphoma

This webinar discusses important statistical concepts using recent literature to evaluate the strengths, weaknesses, reproducibility (validity), and applicability of established and emerging endpoints in patients with non-Hodgkin’s lymphoma and assesses relative efficacy between regimens or cohorts.

See more...

Points - 1.0 CME Credit

How Immune Checkpoint Inhibitors Are Changing the Treatment Landscape for Metastatic Melanoma

A recording of the satellite symposium at the 9th World Congress of Melanoma held in Brisbane, Australia in October 2017, this webinar discusses the current practices and challenges in managing metastatic melanoma and how checkpoint inhibitors affect future management.

See more...

Points - 1.5 CME/CE Credit

Aerosolized Agents for Airway Clearance in Cystic Fibrosis: When, How and Why

This webinar is a roundtable discussion among three international expert faculty on the role of aerosolized agents for improving airway clearance and strategies to improve adherence to therapy for patients with cystic fibrosis.

See more...

Points – RACGP 1 Cat. 2 | ACRRM 1 core

MOTIVATE Course 4: Behavioural Aspects of MOH

MOH is said to be a biobehavioural disorder, with patients often relying on analgesics to function. Comorbid psychiatric disorders are also common among these patients. Learn about strategies for patient education and individualising management.

See more...

Points – RACGP 1 Cat. 2 | ACRRM 1 core

MOTIVATE Course 3: Prevention of MOH

Treatment of MOH may be difficult, and so it is important for patients to understand how to prevent this condition in the first place. As a healthcare professional, learn how to recognise patients at risk of MOH and educate them on how to avoid falling into the cyclical trap of overusing their headache medications.

See more...

Points – RACGP 1 Cat. 2 | ACRRM 1 core

MOTIVATE Course 2: History Taking, Diagnosing, and Treatment of MOH

Taking a proper history plays a big part in diagnosing headache. Using a simulated case study, recall the process of detailed history taking to elicit a comprehensive headache history. Also. learn the different treatment modalities of MOH.

See more...

Points – RACGP 1 Cat. 2 | ACRRM 1 core

MOTIVATE Course 1: Definition and Pathophysiology of MOH

Did you know that excessive use of acute headache medications may be the culprit for frequent headaches? Learn about MOH, its diagnostic criteria and pathophysiology, and the medications associated with it.

See more...